Key result
Specific MYH11 haplotype linked to ~77% lower disease odds.
Why the study?
Mutations in the MYH11 gene cause familial thoracic aortic aneurysm and dissection with patency of the arterial duct, and smooth muscle myosin heavy chain is involved in physiological duct closure. This study investigated whether MYH11 is a susceptibility gene for sporadic, isolated persistent patency of the arterial duct.
Is the MYH11 gene a susceptibility gene for the sporadic occurrence of isolated persistent patency of the arterial duct in Caucasian children?
Case-Control (n=252)
Is the MYH11 gene a susceptibility gene for the sporadic occurrence of isolated persistent patency of the arterial duct in Caucasian children?
Mutations in the MYH11 gene are involved in only rare instances of sporadic, isolated persistent patency of the arterial duct.
Answers are grounded in this paper and cite their sources.
Rare MYH11 variants in sporadic PDA warrant no routine testing; leaves open limited susceptibility role for validation studies.
Persistent patency of the arterial duct is one of the most common congenital cardiac malformations. We recently showed that mutations in the MYH11 gene result in a disease combining familial thoracic aortic aneurysm and dissection, along with patency of the arterial duct. It is also known that the smooth muscle myosin heavy chain is involved in the physiological closure of the arterial duct. With this in mind, we investigated whether the MYH11 gene was a susceptibility gene for sporadic occurrence of isolated persistent patency of the arterial duct. We sequenced the entire coding sequence of the MYH11 gene in 60 Caucasian children with persistent patency born after 36 weeks of gestation. The frequencies of rare genetic variants, and single nucleotide polymorphisms, were compared with 192 normal controls. Two possible functional missense mutations were found in two affected individuals. Another rare variant, specifically p.Arg1535Gln, and two coding polymorphisms, namely p.Ala1234Thr and p.Val1289Ala, had allele frequencies similar to those in controls. Haplotype analysis after estimating linkage disequilibrium was carried out using six polymorphisms. Individual genotypes were distributed similarly among cases and controls. Only one of the seven major haplotypes was significantly less frequent among cases, at 0.07, than among controls, when the figure was 0.22 (OR 0.23 [0.08-0.27]). Our findings suggest that the MYH11 gene is involved in only rare instances when persistent patency of the arterial duct occurs in sporadic fashion.
No takes yet. Share an insight, caveat, or question.
Bonnet et al. (2007) conducted a case-control in Isolated persistent patency of the arterial duct (n=252). MYH11 gene variants and haplotypes vs. 192 normal controls was evaluated on Frequency of major MYH11 haplotypes and rare genetic variants (OR 0.23, 95% CI 0.08-0.27). MYH11 gene sequencing revealed two possible functional missense mutations in 2 of 60 cases and one protective haplotype.
Synapse has enriched 10 related papers. Consider them for comparative context: